Ligand profile
OP1
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01017 — Lysine-arginine-ornithine-binding periplasmic protein
Identifiers
Database identifiers and provenance.
- Ligand ID
OP1- PDB
4pow- UniProt (similar protein)
P35120- Target protein
- KP13_01017
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 156.8
- −1 ≤ LogP ≤ 5 -1.22
- MW ≤ 500 Da 286.3
- LogP ≤ 5 -1.22
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 156.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
[H]/N=C(\N)/NCCC[C@@H](C(=O)O)N1[C@H](CCC1=O)C(=O)O[H]/N=C(\N)/NCCC[C@@H](C(=O)O)N1[C@H](CCC1=O)C(=O)O
InChI=1S/C11H18N4O5/c12-11(13)14-5-1-2-6(9(17)18)15-7(10(19)20)3-4-8(15)16/h6-7H,1-5H2,(H,17,18)(H,19,20)(H4,12,13,14)/t6-,7+/m0/s1InChI=1S/C11H18N4O5/c12-11(13)14-5-1-2-6(9(17)18)15-7(10(19)20)3-4-8(15)16/h6-7H,1-5H2,(H,17,18)(H,19,20)(H4,12,13,14)/t6-,7+/m0/s1
GTRMYGUJZGMZEF-NKWVEPMBSA-NGTRMYGUJZGMZEF-NKWVEPMBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00497
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand OP1 →
- PDB RCSB structure 4pow →
- UniProt UniProt P35120 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “OP1”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01017.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).